AstraZeneca will invest about 200 mln yuan to upgrade its Wu
文 / 小金
2026-09-17 12:01:45
来源:亚金网
AstraZeneca will invest about 200 mln yuan to upgrade its Wuxi production and supply base with a new drug development and supply building to support process development and production for its cardiovascular drug candidates and to back global supply after commercialisation. The 5,800 sq m facility is scheduled to enter service in Q4 2029 and is expected to have annual capacity of about 400 mln tablets. Upon completion, the Wuxi site will engage in commercial-stage process development and could become AstraZeneca’s first APAC base capable of supporting a new drug’s global launch and supply.
